Anticoagulant and antiplatelet therapy in heart failure

Curr Opin Cardiol. 1997 May;12(3):276-87. doi: 10.1097/00001573-199705000-00009.
No abstract available

Publication types

  • Review

MeSH terms

  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Cause of Death
  • Heart Failure / drug therapy*
  • Heart Failure / mortality
  • Humans
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Sinus Thrombosis, Intracranial / mortality
  • Sinus Thrombosis, Intracranial / prevention & control
  • Survival Rate
  • Thromboembolism / mortality
  • Thromboembolism / prevention & control
  • Treatment Outcome
  • Ventricular Dysfunction, Left / drug therapy
  • Ventricular Dysfunction, Left / mortality

Substances

  • Anticoagulants
  • Platelet Aggregation Inhibitors